EphB4 receptor inhibitors (Sanford)

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug NameEphB4 receptor inhibitors (Sanford)
Drug Alias Nameephrin-type B receptor 4 inhibitors (Sanford)
ClassificationBiologics > Protein drugs > Recombinant polypeptide
Mechanisms of ActionEphrin type-B receptor 4 antagonists
TargetsEphrin type-B receptor 4
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesSanford Burnham Prebys Medical Discovery Institute
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesSanford Burnham Prebys Medical Discovery Institute
Active IndicationsN/A
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A